Marriott Marquis Washington, DC
Marquis Ballroom, Salon 7/8
901 Massachusetts Ave NW
Washington, DC 20001
6:00 PM: Registration and Dinner
6:30 PM: Welcome and Introduction—Daniel Pallin, MD, MPH
6:50 PM: Master Class—Michael Postow, MD
7:20 PM: Practicum—Cases presented by Marianne Davies, DNP, ACNP, AOCNP; Discussion by all faculty
7:45 PM: Audience–Faculty Q&A, Reflections, and Conclusions—All faculty, moderated by Daniel Pallin, MD, MPH
8:00 PM: Adjourn
The spotlight is on cancer in emergency medicine—why now, and why should you care? The oncology treatment landscape is changing—what does the increasing role and use of cancer immunotherapies mean for those working in the ED? Emergency medicine specialists are often called upon to evaluate and manage patients with a wide variety of oncologic emergencies—what are the latest recommendations and best practices for recognition and management of adverse reactions associated with cancer immunotherapies and how can we improve outcomes in these patients? These and many other interesting topics will be addressed in this interactive and engaging CME/CE satellite symposium led by Dr. Daniel Pallin.
Upon completion of this activity, participants will be able to:
This activity has been designed to meet the educational needs of emergency medicine physicians, nurse practitioners, physician assistants, and other healthcare professionals involved in the management of acutely unwell patients with cancer in emergency departments.
The purpose of this activity is to improve the knowledge and competence of nurses concerning recognition, evaluation, and management of oncologic emergencies in patients with cancer presenting to emergency departments.
In order to receive credit, participants must attend the live activity and complete the request for credit. There are no prerequisites and there is no fee to participate in this activity or to receive CME/CE credit. Statements of Credit are awarded upon completion of the request for credit at the end of the post-test.
Release and Expiration Date: October 28, 2017
Time to Complete: 90 minutes
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CE activity during the past 12 months.
Daniel Pallin, MD, MPH
Assistant Professor of Emergency Medicine
Harvard Medical School
Research Director, Department of Emergency Medicine
Brigham and Women’s Hospital
Marianne Davies, DNP, ACNP, AOCNP
Yale School of Nursing
Oncology Nurse Practitioner
Yale Comprehensive Cancer Center & Smilow Cancer Center
New Haven, Connecticut
Michael Postow, MD
Memorial Sloan Kettering Cancer Center
New York, New York
Kadrin Wilfong, MD
PVI, PeerView Institute for Medical Education
The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Learning Institute, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Approved by the American College of Emergency Physicians for a maximum of 1.5 hours of ACEP Category I credit.
Medical Learning Institute, Inc.
Provider approved by the California Board of Registered Nursing, Provider Number 15106, for 1.5 contact hour(s).
This CME/CE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.
This activity is supported by an independent educational grant from AstraZeneca.
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.